ATE504289T1 - Ausstossflüssigkeit und ausstossverfahren - Google Patents

Ausstossflüssigkeit und ausstossverfahren

Info

Publication number
ATE504289T1
ATE504289T1 AT07831968T AT07831968T ATE504289T1 AT E504289 T1 ATE504289 T1 AT E504289T1 AT 07831968 T AT07831968 T AT 07831968T AT 07831968 T AT07831968 T AT 07831968T AT E504289 T1 ATE504289 T1 AT E504289T1
Authority
AT
Austria
Prior art keywords
exhaust
liquid
compound
group
solution
Prior art date
Application number
AT07831968T
Other languages
English (en)
Inventor
Yohei Masada
Masaru Sugita
Hideki Kaneko
Naoko Sakurada
Original Assignee
Canon Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canon Kk filed Critical Canon Kk
Application granted granted Critical
Publication of ATE504289T1 publication Critical patent/ATE504289T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • A61M15/025—Bubble jet droplet ejection devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mechanical Engineering (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Particle Formation And Scattering Control In Inkjet Printers (AREA)
  • Peptides Or Proteins (AREA)
  • Ink Jet (AREA)
  • Ink Jet Recording Methods And Recording Media Thereof (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Treating Waste Gases (AREA)
AT07831968T 2006-12-04 2007-11-09 Ausstossflüssigkeit und ausstossverfahren ATE504289T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006327031A JP4777225B2 (ja) 2006-12-04 2006-12-04 吐出用液体及び吐出方法
PCT/JP2007/072238 WO2008069012A2 (en) 2006-12-04 2007-11-09 Ejection liquid and ejection method

Publications (1)

Publication Number Publication Date
ATE504289T1 true ATE504289T1 (de) 2011-04-15

Family

ID=39343526

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07831968T ATE504289T1 (de) 2006-12-04 2007-11-09 Ausstossflüssigkeit und ausstossverfahren

Country Status (11)

Country Link
US (2) US20100069290A1 (de)
EP (1) EP2091513B1 (de)
JP (1) JP4777225B2 (de)
KR (1) KR20090086279A (de)
CN (1) CN101547684B (de)
AT (1) ATE504289T1 (de)
AU (1) AU2007330137A1 (de)
CA (1) CA2671634C (de)
DE (1) DE602007013796D1 (de)
RU (1) RU2420303C2 (de)
WO (1) WO2008069012A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4784789B2 (ja) * 2009-06-29 2011-10-05 セイコーエプソン株式会社 吐出用液体及び生体試料の吐出方法
JP5605760B2 (ja) * 2010-01-18 2014-10-15 セイコーエプソン株式会社 吐出用液体、生体試料の吐出方法、及び化合物
WO2012118236A1 (ja) * 2011-03-03 2012-09-07 帝人株式会社 繊維成形体
CN117769464A (zh) * 2021-06-24 2024-03-26 诺信公司 具有闭环自动堵塞检测的非接触式超声喷嘴清洁器

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7316591A (en) * 1990-02-28 1991-09-18 Upjohn Company, The Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
US5723496A (en) * 1991-03-05 1998-03-03 The Regents Of University Of California Method for prevention and treatment of harmful effects of intracellular acidosis
US6072075A (en) * 1997-05-22 2000-06-06 The Regents Of The University Of California Guanidinylation reagents
US6767892B1 (en) * 1997-11-07 2004-07-27 Chrion Corporation Compositions providing for increased IGF-I solubility
JP4147234B2 (ja) * 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、カートリッジ及び吐出装置
US7594507B2 (en) * 2001-01-16 2009-09-29 Hewlett-Packard Development Company, L.P. Thermal generation of droplets for aerosol
EP1248108B1 (de) * 2001-03-29 2011-08-31 Canon Kabushiki Kaisha Verfahren zum Zellscreening und dafür geeignete Substrata
EP1389137B1 (de) 2001-05-21 2006-07-19 InJet Digital Aerosols Limited Zusammensetzungen für die freisetzung von protein auf dem pulmonalen weg
CA2436011C (en) * 2001-11-22 2009-03-10 Canon Kabushiki Kaisha Liquid ejection head
US7726303B2 (en) 2003-02-25 2010-06-01 Hewlett-Packard Development Company, L.P. Controlled medicament ejection
JP4533044B2 (ja) * 2003-08-27 2010-08-25 キヤノン株式会社 センサ
US20060079673A1 (en) * 2004-08-02 2006-04-13 Paul Glidden Polynucleotides encoding tRNA synthetase fragments and uses thereof
US7659987B2 (en) * 2004-09-16 2010-02-09 Canon Kabushiki Kaisha Device and method for acquiring information on objective substance to be detected by detecting a change of wavelength characteristics on the optical transmittance
JP4147235B2 (ja) * 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、液滴化方法、液体吐出カートリッジ及び吐出装置
GB0503434D0 (en) * 2005-02-18 2005-03-30 Senexis Ltd Amyloid-binding peptides, analogues and uses thereof
JP4646669B2 (ja) * 2005-03-30 2011-03-09 キヤノン株式会社 吐出用液体、吐出方法、液滴化方法、カートリッジ及び吐出装置
JP4689340B2 (ja) * 2005-05-02 2011-05-25 キヤノン株式会社 吐出用液体医薬組成物
KR101355868B1 (ko) * 2005-08-02 2014-01-27 알즈켐 아게 구아니디노아세트산 성분에 기반한 액체 제제
US8028554B2 (en) * 2006-09-03 2011-10-04 Essence Security International Ltd. Electronic cylinder lock apparatus and methods

Also Published As

Publication number Publication date
RU2420303C2 (ru) 2011-06-10
WO2008069012A3 (en) 2008-08-07
CN101547684B (zh) 2012-12-12
CN101547684A (zh) 2009-09-30
CA2671634A1 (en) 2008-06-12
AU2007330137A1 (en) 2008-06-12
DE602007013796D1 (de) 2011-05-19
EP2091513B1 (de) 2011-04-06
CA2671634C (en) 2012-03-13
RU2009125531A (ru) 2011-01-20
WO2008069012A2 (en) 2008-06-12
US20130068784A1 (en) 2013-03-21
EP2091513A2 (de) 2009-08-26
KR20090086279A (ko) 2009-08-11
US20100069290A1 (en) 2010-03-18
JP2008137967A (ja) 2008-06-19
JP4777225B2 (ja) 2011-09-21

Similar Documents

Publication Publication Date Title
ES2683372T3 (es) Derivados de GLP-1 acilados con un conector nuevo
CY1112185T1 (el) Σταθερο συμπλοκο δραστικων ουσιων απο αλατα των o-ακετυλοσαλικυλικων οξεων με βασικα αμινοξεα και γλυκινη
BRPI0515649A (pt) processo para preparação de composições de anticorpos altamente concentradas e processo para concentrar proteìnas
DK1778720T3 (da) Antimikrobielle peptider omfattende et arginin- og/eller lysinholdigt motiv
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
BR112014027244A2 (pt) derivados de benzamida para inibição da atividade de abl1, abl2 e bcr-abl1
CR10158A (es) N-sulfonilación selectiva de alcoholes 2-amino trifluoroalquilo sustituidos
DK1893587T3 (da) Fremgangsmåde til fremstilling af dihydroquinazoliner
AR067701A1 (es) Metodos y composiciones utiles para la preparacion de inhibidores del contransportador de sodio y glucosa 2
EA200870217A1 (ru) 4-арил-2-аминопиримидины или 4-арил-2-аминоалкилпиримидины в качестве модуляторов jak-2 и содержащие их фармацевтические композиции
BR112015000088A2 (pt) composições farmacêuticas compreendendo rifamixinaa e aminoácidos, método de preparação e uso das mesmas
EA201000814A1 (ru) 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств
BRPI0810305A2 (pt) "vetor, molécula de ácido nucléico substancialmente isolada, célula hospedeira, composição farmacêutica, uso de uma molécula de ácido nucléico, uso de um vetor, uso de uma célula hospedeira e uso de uma composição"
WO2009083225A3 (en) Antibody-containing formulation for the use for treating cardiovascular diseases associated with atherosclerosis
BR112014021993A2 (pt) detecção da variação de nucleotídeo em sequência de ácido nucleico alvo através de ensaio de clivagem e extensão de pto
EA200970124A1 (ru) Производные 2-арилиндола в качестве ингибиторов npges-1
ATE504289T1 (de) Ausstossflüssigkeit und ausstossverfahren
HRP20161145T1 (hr) Postupak za pripravu l-argininske soli perindoprila
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
EA201070090A1 (ru) Композиция для укладки волос
EA201070194A1 (ru) Стабильная жидкая фармацевтическая композиция на основе тразодона
AR075097A1 (es) Sales y formas polimorficas cristalinas de [4-(6-fluoro-7-metilamino-2,4-dioxo-1,4-dihidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-sulfonil urea, composiciones farmaceuticas que las contiene, metodo para prepararlas y uso de las mismas en el tratamiento de enfermedades cardiovasculares asocia
NO20073549L (no) Fremgangsmate for fremstilling av organiske forbindelser
AR057909A1 (es) Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
DK1931636T3 (da) Isoquinoliner som IGF-1R-inhibitorer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties